A Registry-study of ELZONRIS in Participants With BPDCN
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The main goal of this registry study is to investigate the effectiveness and safety of tagraxofusp in the treatment of adult participants with BPDCN in the real-world clinical practice setting.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Postawiona diagnoza BPDCN potwierdzona badaniem szpiku kostnego i testami biologicznymi (CD123, CD4, CD56)
- •Planujesz rozpocząć lub już rozpocząłeś leczenie tagraxofuspem w ciągu 6 miesięcy przed lub w momencie podpisania zgody na udział w badaniu
✗ Disqualifies
- •Uczestniczysz lub planujesz uczestniczyć w innym badaniu dotyczącym leczenia BPDCN
- •Bierzesz udział w innym eksperymentalnym badaniu medycznym
- •Masz znane uczulenie na składniki leku tagraxofusp
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 25, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (41)
Medical University Innsbruck
Innsbruck, Austria
Ordensklinikum Linz Krankenhaus der Elisabethinen Linz
Linz, Austria
Salzburg Cancer Research Institute (SCRI)
Salzburg, Austria
Medizinische Universitat Wien, Department for Internal Medicine I, Division of Hematology and Haemostaseology
Vienna, Austria
Universitätsklinikum Augsburg
Augsburg, Germany
Hospital Bielefeld
Bielefeld, Germany
Klinikum Chemnitz
Chemnitz, Germany
University Clinic of Frankfurt
Frankfurt, Germany
University clinic of Freiburg
Freiburg im Breisgau, Germany
Universitätsmedizin Halle
Halle, Germany
Asklepios Hamburg
Hamburg, Germany
University Medical Center Hamburg - Eppendorf
Hamburg, Germany
Community Hospital Kiel
Kiel, Germany
Universitätsklinikum Leipzig Klinik und Poliklinik für Hämatologie, Zelltherapie und Hämostaseologie
Leipzig, Germany
Universitätsklinikum Schleswig-Holstein
Lübeck, Germany
Technical University of Munich
Munich, Germany
Oldenburgh
Oldenburg, Germany
Medizinische Klinik Universitat Tübingen
Tübingen, Germany
AON SS Antonio e Biagio e C Arrigo Alessandria SOC Ematologia
Alessandria, Italy
AOU di Bologna - Policlinico S. Orsola-Malpighi - UOC Ematologia
Bologna, Italy
CTC U.O di Ematologia con Trapianto di Midollo Osseo - Catania
Catania, Italy
ASO S. Croce e Carle - Cuneo - SC Ematologia
Cuneo, Italy
AOU Arcispedale Sant'Anna Cona (FE) - UOC Ematologia e Fisiopatologia della Coagulazione
Ferrara, Italy
AOU Careggi - Firenze - SOD Ematologia
Florence, Italy
IRCCS AOU San Martino - Genova - UO Clinica Ematologica
Genova, Italy
UO Ematologia e Terapie Cellulari, IRCCS Ospedale Policlinico San Martino - Genoa
Genova, Italy
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Milano - Ematologia
Milan, Italy
SC Ematologia - ASST Grande Ospedale Metropolitano Niguarda
Milan, Italy
AOU Federico II - UOC Ematologia e Trapianti di Midollo
Naples, Italy
AOU di Padova - UO Ematologia
Padova, Italy
AO Ospedali Riuniti Villa Sofia Cervello Palermo - UO Ematologia con UTMO
Palermo, Italy
Fondazione IRCCS Policlinico San Matteo Pavia UO Ematologia
Pavia, Italy
AO di Perugia, Ospedale S. Maria della Misericordia - Ematologia E Trapianto Midollo Osseo
Perugia, Italy
ASL Pescara - Presidio Ospedaliero "Spirito Santo" - UOC Ematologia Clinica
Pescara, Italy
AOU Policlinico Tor Vergata - Roma - Ematologia
Roma, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Roma - Area Ematologica
Roma, Italy
AOU 'San Giovanni di Dio e Ruggi d'Aragona' Salerno - UOC Ematologia
Salerno, Italy
AOU Città della Salute e della Scienza - Ospedale S. G. Battista Molinette - Torino - SC Ematologia
Torino, Italy
ASUI di Udine - Presidio Ospedaliero "Santa Maria della Misericordia" - Clinica Ematologica
Udine, Italy
Insel Gruppe AG, Bern University Hospital
Bern, Switzerland
Luzerner Kantonsspital
Lucerne, Switzerland
Trial contact
Stemline Trials
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/26/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.